Quarterly Result21 May 2026, 07:51 pm
Link Pharma Chem Ltd Reports FY26 Loss of ₹102.73 Lakhs
AI Summary
Link Pharma Chem Ltd's audited financial results for the year ended March 31, 2026, reveal a loss of ₹102.73 lakhs. The Board of Directors approved these results along with the re-appointment of Mr. Satish G. Thakur as Chairman and Wholetime Director, and Mr. Rishikesh Thakur as Managing Director, both subject to shareholder approval. Revenue from operations stood at ₹2,743.15 lakhs for the year ended March 31, 2026.
Key Highlights
- Link Pharma Chem reports a loss of ₹102.73 lakhs for the year ended March 31, 2026.
- Revenue from operations for FY26 is ₹2,743.15 lakhs.
- Satish G. Thakur re-appointed as Chairman and Wholetime Director.
- Rishikesh Thakur re-appointed as Managing Director.
- Board approved audited financial results on May 21, 2026.
Price Impact
More from LINKPH